Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan for Menstrual Migraine
NCT00111722Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in menstrual migraine comparing Rizatriptan 10 mg with Placebo (2 arms). Primary endpoint: Percentage of patients with 2 hour pain relief. Started May 2005; status: completed.
02
Drugs
rizatriptan
03
Conditions
menstrual migraine
Beyond the preview
Go deeper on NCT00111722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111722.